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In neonatal jaundice, high levels of unconjugated bilirubin (UCB) may induce neurological
dysfunction (BIND). Recently, it was observed that UCB induces alterations on brain
microvasculature, which may facilitate its entrance into the brain, but little is known about
the steps involved. To evaluate if UCB damages the integrity of human brain microvascular
endothelial cells (HBMECs), we used 50 or 100μM UCB plus human serum albumin,
to mimic the neuropathological conditions where levels of UCB free species correspond
to moderate and severe neonatal jaundice, respectively. Our results point to a biphasic
response of HBMEC to UCB depending on time of exposure. The early response includes
increased number of caveolae and caveolin-1 expression, as well as upregulation of
vascular endothelial growth factor (VEGF) and its receptor 2 (VEGFR-2) with no alterations
of the paracellular permeability. In contrast, effects by sustained hyperbilirubinemia are the
reduction in zonula occludens (ZO)-1 and β-catenin levels and thus of tight junctions (TJ)
strands and cell-to-cell contacts. In addition, reduction of the transendothelial electrical
resistance (TEER) and increased paracellular permeability are observed, revealing loss
of the barrier properties. The 72h of HBMEC exposure to UCB triggers a cell response
to the stressful stimulus evidenced by increased autophagy. In this later condition, the
UCB intracellular content and the detachment of both viable and non-viable cells are
increased. These findings contribute to understand why the duration of hyperbilirubinemia
is considered one of the risk factors of BIND. Indeed, facilitated brain entrance of the free
UCB species will favor its parenchymal accumulation and neurological dysfunction.
Keywords: blood-brain barrier, caveolae, endothelial cells, integrity, intercellular junctions, unconjugated bilirubin,
VEGF, VEGFR-2
INTRODUCTION
The blood-brain barrier (BBB) is a dynamic and complex inter-
face between blood and the central nervous system (CNS) that
strictly controls the exchanges between the blood and brain com-
partments, therefore playing a key role in brain homeostasis.
The integrity and BBB barrier characteristics are mainly achieved
through the presence of tight (TJ) and adherens junctions (AJ),
which are able to restrict and regulate the passage of molecules
through the paracellular pathway and are also involved in com-
plex signaling mechanisms (Abbott et al., 2010; Cardoso et al.,
2010). They are organized by networks of transmembrane pro-
teins connected to the cytoskeleton by cytosolic proteins, such
as the TJ proteins, occludin and the zonula occludens (ZO)-1,
and the AJ proteins, vascular endothelial (VE)-cadherin, and
β-catenin (Cardoso et al., 2010).
Neuroinflammation, acute hypoxia/ischemia, and several neu-
rodegenerative diseases have been pointed to perturb BBB
integrity (Wispelwey et al., 1988; Abbruscato and Davis, 1999;
Davies, 2002). LPS revealed to lower the transendothelial
electrical resistance (TEER), to increase the permeability to
sodium fluorescein (NA-F) and to promote changes in the linear
shape along the junctions between cells to a more zigzap shape
morphology, altering the selective barrier function of TJ at the
BBB (Sumi et al., 2010). Alterations in the subcellular localization
of TJ proteins, including ZO-1 and occludin, leading to hyperper-
meability of the BBB, were also observed by hydrogen peroxide
(Lee et al., 2004; Fischer et al., 2005), as well as by reactive oxy-
gen species (Schreibelt et al., 2007) and oxidative stress-induced
by several compounds (Haorah et al., 2007). Occludin levels were
also decreased, suggesting that vascular endothelial growth factor
(VEGF) increases permeability by reducing occludin expression
and disrupting ZO-1 and occludin organization, which leads to
TJs disassembly. Accordingly, occludin and ZO-1 were suggested
as downstream effectors of the VEGF signaling pathway (Petty
and Lo, 2002). In addition, β-catenin evidenced to disappear
subsequently to leukocyte extravasation (Petty and Lo, 2002).
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More recently, it was demonstrated that early life stress, both
prenatal and postnatal, increase transvascular transport medi-
ated by caveolae in brain endothelial cells (Gomez-Gonzalez and
Escobar, 2009). Interestingly, increased expression of caveolin-1,
an integral caveolar membrane protein, evidenced to be asso-
ciated with early BBB breakdown and edema in brain injury
(Nusrat et al., 2000; Song et al., 2007; Nag et al., 2009a). Caveolin-
1 was also indicated to control signaling pathways that lead to
the disruption of TJ proteins (Zhong et al., 2008). In partic-
ular, the interaction of caveolin-1 with VEGF and its receptor
2 (VEGFR-2) indicates that caveolin-1 plays multiple roles in
the VEGF-induced signaling cascade and, consequently, on the
endothelial permeability (Chen et al., 2002; Labrecque et al.,
2003). Thus, caveolae and caveolin-1 have an important role in
early BBB breakdown and are considered potential therapeutic
targets.
Elevated levels of unconjugated bilirubin (UCB) during the
neonatal period may be responsible for the occurrence of UCB-
induced neurological dysfunction (BIND) associated to minor
brain deficits, or bilirubin encephalopathy commonly known as
kernicterus (Cohen et al., 2010; Shapiro, 2010). Therefore, the
passage of UCB across the BBB into the CNS appears to be a cru-
cial first step in the development of kernicterus (Sequeira et al.,
2007). Autopsy findings in kernicterus cases include brain edema
(Perlman et al., 1997), increased VEGF expression, and infiltra-
tion of erytrocytes and albumin into the brain parenchyma (Brito
et al., 2011), features resulting from an enhanced permeability of
vascular walls. Despite the indication that brain vascular system
may be compromised during severe hyperbilirubinemia, entrance
of UCB into the brain has been mainly attributed to simple
diffusion of the UCB fraction not bound to albumin, usually des-
ignated as free UCB (Bf), through the endothelial cells (Diamond
and Schmid, 1966; Wennberg, 2000). Toxicity is believed to occur
when concentrations of Bf are too high, favoring its precipita-
tion, and when risk factors such as prematurity and prolonged
exposure are associated to the neonatal hyperbilirubinemia, thus
enhancing the probability of BIND (Wennberg, 2000; Ahlfors,
2001).
In spite of the increased awareness of UCB effects to brain
cells (Brites and Brito, 2012), knowledge about its passage across
the endothelial monolayer, the rate in which this passage is
achieved, and its effects on the integrity of the brain endothe-
lial barrier is scarce (Akin et al., 2002; Sequeira et al., 2007).
Our own previous study has shown that the endothelial lining
is susceptible to UCB (Palmela et al., 2011), since high levels of
the molecule increased endothelial cell death, compromised the
cell antioxidant capacities, affected the expression of important
endothelial proteins and, most notably, increased the production
of mediators with great implications to the integrity and perme-
ability of the BBB, such as nitric oxide and VEGF. More recently,
our group has confirmed that UCB affects rat primary brain
endothelial cells, inducing cell death, impairing P-glycoprotein
function and activating metalloproteinases (Cardoso et al., 2012).
Importantly, such study evaluated the integrity of the endothelial
monolayers, either in mono or in co-cultures with astrocytes, and
showed a decreased TEER and increased permeability after UCB
exposure.
If the BBB is disturbed during hyperbilirubinemia, it is likely
that the entrance of Bf or even albumin-bound UCB into the
brain will be facilitated (Wennberg, 2000). Therefore, we decided
to undertake a deeper analysis of the integrity of the endothelial
lining upon UCB exposure to test the harmful effects of a short
and sustained hyperbilirubinemia on BBB properties. To this end,
we further explored the dynamics of UCB interaction with a
human brain microvascular endothelial cell (HBMEC) mono-
layer, considered a simplified in vitro model of the human BBB,
throughout incubation time. Our results indicate biphasic effects
of UCB on the HBMEC that depend on the time of interac-
tion. A short exposure to UCB increases the protein levels of
caveolin-1, VEGF and VEGFR-2 and already elicits the release
of small endothelial cell vesicles. In the late response UCB trig-
gers a reduction of ZO-1 and β-catenin levels, loss of TJ strands
and impairment of the cohesion between endothelial cells, with
the consequent decrease in TEER and increase in permeabil-
ity. Interestingly, in this last condition there is an increase in
autophagy, thus indicating the activation of the cellular degra-
dation system. Collectively, our findings support the hypothesis
that a sustained and severe hyperbilirubinemia, by inducing BBB
endothelial disruption, facilitates BIND, thus requiring a preven-
tive clinical intervention.
MATERIALS ANDMETHODS
CHEMICALS
The basal medium Roswell Park Memorial Institute (RPMI)
1640, antibiotic-antimycotic solution, human serum albumin
(HSA) (fraction V, fatty acid free), bovine serum albumin (BSA),
Hoechst 33258 dye, sodium fluorescein, and UCB were purchased
from Sigma Chemical Co. (St. Louis, MO, USA). Non-essential
amino acids (NEAA), sodium pyruvate, L-glutamine, fetal bovine
serum (FBS), and minimum essential medium (MEM) vita-
mins were from Biochrom AG (Berlin, Germany). Nuserum
IV and rat-tail collagen I were acquired from BD Biosciences
(Erembodegem, Belgium). Rabbit anti-β-catenin, mouse anti-
ZO-1, rabbit anti-tricellulin, Alexa Fluor 488 goat anti-rabbit
IgG, and Alexa Fluor 594 goat anti-mouse IgG were purchased
from Invitrogen (Carlsbad, CA, USA). Rabbit anti-caveolin-1,
rabbit anti-microtubule-associated protein 1 light chain-3 (LC3),
LumiGLO, and cell lysis buffer were acquired from Cell Signaling
(Beverly, MA, USA). Horseradish peroxidase-labeled goat anti-
rabbit IgG, mouse anti-glyceraldehyde 3-phosphate dehydroge-
nase (GAPDH), rabbit anti-VEGF, and mouse anti-VEGFR-2
were acquired from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA, USA). Rabbit anti-lamin B1 was from Abcam (Cambridge,
UK). Pefabloc® SC AEBSF was obtained from Roche Applied
Science (Mannheim, Germany). Horseradish peroxidase-labeled
goat anti-mouse IgG, nitrocellulose membrane and Hyperfilm
ECL were from Amersham Biosciences (Piscataway, NJ, USA). All
other chemicals were of analytical grade and were purchased from
Merck (Darmstadt, Germany).
CELL CULTURE AND TREATMENT
We have previously used an HBMEC line as a simplified model
of the human BBB to evaluate the effects of UCB on cell death,
cytokine mRNA expression and release, as well as on nitrosative
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stress (Palmela et al., 2011). This cell line was derived from pri-
mary cultures of HBMEC transfected with SV40 large T antigen
(Stins et al., 2001) and was cultured in RPMI medium sup-
plemented with 10% FBS, 10% NuSerum IV, 1% NEAA, 1%
MEM vitamins, 1mM sodium pyruvate, 2mM L-glutamine, and
1% antibiotic-antimycotic solution. For immunocytochemistry,
electron microscopy and Western blot studies, cells were seeded
at a density of 5 × 104 cell/mL in collagen I-coated coverslips
and plates, respectively, and treated after 2 days in culture. For
integrity studies, cells were seeded on collagen I-coated polyester
transwell inserts (0.4μm, Corning Costar Corp., USA) at a den-
sity of 8 × 104 cell/insert and treated after 8 days in culture. All
experiments were performed at confluence. Endothelial cultures
were maintained at 37◦C in a humid atmosphere enriched with
5% CO2.
UCB was purified according to the method of McDonagh and
Assisi (1972) and a 10mM stock solution of UCB was prepared
in 0.1M NaOH and used immediately after preparation. The pH
value was restored to 7.4 by addition of equal amounts of 0.1M
HCl, and all the procedures were performed under light pro-
tection to avoid photodegradation. Confluent monolayers of the
HBMEC line were incubated with 50 or 100μM UCB, or no
addition (control), in the presence of 100μM HSA, for 4, 24,
48, and 72 h. The incubation medium consisted in the regular
medium without FBS and Nuserum to avoid disturbance of the
final concentration of albumin in the incubation medium.
In the integrity experiments, endothelial cells were cultured on
semipermeable filters with two well-defined compartments: the
apical or upper compartment, which can be considered as the
“blood-side” where UCB and HSA were added, and the baso-
lateral or lower compartment, which is considered the “brain
side.” At the end of each incubation period, and after TEER
measurement, the cultured inserts were used for permeability
studies and media from the upper and lower chambers were
collected for Bf measurements. In separate experiments, the
cells from the UCB-incubated inserts were collected for UCB
extraction with chloroform and the medium of the upper cham-
ber was collected for evaluation of the number of detached
cells.
DETERMINATION OF Bf LEVELS AND UCB CELLULAR CONTENT
Among the methods used to measure Bf, the peroxidase method
is considered practical and reliable, and has been extensively
employed (Roca et al., 2006; Ahlfors et al., 2009). Thus, in
the present study, we used this method to evaluate Bf lev-
els in our two UCB/HSA molar ratio conditions (Roca et al.,
2006).
After determining the starting Bf levels in the two UCB condi-
tions, we monitored Bf levels in the media of the upper and lower
chambers of the treated inserts (4–72 h). In order to evaluate the
intracellular content of UCB, a chloroform extraction was accom-
plished based on the study of Brito et al. (2000). Briefly, after lysis
of the HBMEC monolayer, each sample was mixed with equal
volumes of chloroform. After vortex shaking and centrifugation,
UCB concentration in the chloroform extract was determined by
direct measurement of the absorption at 454 nm. Results were
expressed as nmol of UCB per mg of protein.
TEER MEASUREMENTS
TEER evaluation was performed using an EndOhm™ cham-
ber coupled to an EVOMX resistance meter (World Precision
Instruments, Inc., USA). Readings were collected before UCB
addition (time 0) and after 4, 24, 48, and 72 h of exposure.
Results are shown as percentage of variation from average control
readings, after deducting the empty insert values.
PERMEABILITY STUDIES
In order to evaluate the selective paracellular permeability of the
HBMEC monolayer after UCB exposure, a permeability assay
was conducted with sodium fluorescein (SF) (molecular weight:
376Da). The permeability was determined as described by
Veszelka et al. (2007). Briefly, cell culture inserts were transferred
to 12-well plates containing Ringer–Hepes solution (118mM
NaCl, 4.8mM KCl, 2.5mM CaCl2, 1.2mM MgSO4, 5.5mM
D-glucose, 20mM Hepes, pH 7.4) in the basolateral compart-
ments. The SF solution (10mg/mL SF in 1% BSA solution in
Ringer–Hepes) was added to the upper chambers. The inserts
were transferred to new wells at 20, 40, and 60min. Lower
chamber solutions were collected to determine fluorescein lev-
els (Hitachi F-2000 fluorescence spectrophotometer, excitation:
440 nm and emission: 525 nm). Flux across cell-free inserts was
also measured. The endothelial permeability coefficient Pe was
calculated as described by Deli et al. (2005).
EVALUATION OF DETACHED CELLS
At the end of the 72 h period of incubation, the number of viable
and non-viable cells in suspension in the upper chamber of the
UCB-treated inserts was measured. After media centrifugation,
the cell pellet was recovered in RPMI medium and cells were
counted with Trypan blue dye exclusion test. Results were shown
as number of viable and non-viable cells per insert.
IMMUNOCYTOCHEMISTRY
Immunostaining studies were performed to evaluate UCB effects
on several relevant proteins that direct or indirectly affect the
endothelial barrier functions. The proteins studied included the
TJ protein ZO-1, the AJ protein β-catenin, the caveolae-mediated
transcytosis protein caveolin-1, as well as VEGF and its receptor
VEGFR-2. Detection of these proteins was performed using the
primary antibodies mouse anti-ZO-1, rabbit anti-β-catenin, rab-
bit anti-caveolin-1, rabbit anti-VEGF and mouse anti-VEGFR-2
(all dilutions 1:100), and the secondary antibodies Alexa Fluor
488 goat anti-rabbit and Alexa Fluor 594 goat anti-mouse
(1:500). Fluorescence was visualized using a DFC 490 camera
(Leica, Germany) adapted to an AxioScope.A1 microscope (Zeiss,
Germany). For total fluorescence analysis, fluorescence of five
random microscopic fields was acquired per sample. Evaluation
of fluorescence intensity was determined using ImageJ 1.29x soft-
ware (N.I.H., USA) and results were expressed as fold change
(mean fluorescence per number of cells vs. control samples).
WESTERN BLOT ANALYSIS
Total and region-specific β-catenin were further evaluated
by Western blot. Subcellular fractionation was performed as
described by Abcam (Dr. Richard Pattern). Briefly, cells were
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lysed with fractionation buffer (250mM sucrose, 20mM HEPES,
10mM KCl, 1.5mM MgCl2, 1mM EDTA, 1mM EGTA, 1mM
DTT, and 1mM Pefabloc) and passed through a 25G needle.
The nuclear pellet was collected after centrifugation and the
supernatant (cytoplasmic and membrane fractions) was then
ultracentrifuged (100,000 g) for 1 h. The cytoplasmic fraction
(supernatant) was removed and the pellet (membrane fraction)
was ressuspended in cell lysis buffer. The efficiency of fraction-
ation was confirmed with the detection of GAPDH enrichment
in the cytoplasmic fraction, Lamin B1 in the nuclear fraction and
tricellulin in the membrane region. Results were normalized to
total protein staining with Amido Black (Aldridge et al., 2008)
due to UCB-induced changes in the expression of the membrane
proteins. Therefore, in order to ensure consistency of results, we
normalized the intensity of β-catenin in all the extracts to total
protein staining.
In order to study the HBMEC process of autophagy after
UCB exposure, the conversion of LC3-I (free form) to LC3-II
(phosphatidylethanolamine-conjugated form) was also evalu-
ated by Western blot in total protein extracts. The Western
blot assays were carried out as previously described (Fernandes
et al., 2006). Briefly, total or region-specific protein extracts were
separated on a 8 or 12% SDS-PAGE (for β-catenin and LC3
detection, respectively). Following electrophoretic transfer onto
a nitrocellulose membrane and blocking with 5% milk solution,
the blots were incubated with primary antibody overnight at
4◦C [rabbit anti-LC3 (1:1000), rabbit anti-β-catenin (1:1000) or
mouse anti-β-actin (1:5000)] and with horseradish peroxidase-
labeled secondary antibody [anti-mouse (1:5000) or anti-rabbit
(1:5000)] for 1 h at room temperature. Protein bands were
detected by LumiGLO and visualized by autoradiography with
Hyperfilm ECL.
ELECTRON MICROSCOPY (EM) AND FREEZE-FRACTURE
For scanning EM, cells and vesicles released into the culture
medium were doubly fixed with 2% glutaraldehyde in 0.1M
phosphate buffer (PB) and 1% osmium tetroxide in 0.1M PB,
and dehydrated with a graded series of ethanol. Samples were
then critical-point dried, sputter coated, and observed by a JEOL
JSM-5800LV scanning electron microscope (Tokyo, Japan) at an
acceleration voltage of 15 kV. For transmission EM, cells were
prepared as described above and then embedded in epoxy resin.
Ultrathin sections were stained with uranyl acetate and lead cit-
rate and observed with a Hitachi H-7500 transmission electron
microscope (Tokyo, Japan) at an acceleration voltage of 80 kV.
For freeze-fracture EM cells, fixed as described, were immersed
overnight in 30% glycerol in 0.1M PB and then frozen in liq-
uid nitrogen. Frozen samples were fractured at −100◦C and
platinum-shadowed unidirectionally at an angle of 45◦ in BAL-
TEC BAF060 Freeze Etching System. Samples were picked up
on formovar-filmed grids and examined with a Hitachi H-7500
electron microscope at 100 kV.
STATISTICAL ANALYSIS
Results are expressed as means ± SEM from, at least, three sep-
arate experiments. Significant differences between groups were
determined by the two-tailed t-test performed on the basis of
equal and unequal variance as appropriate. Statistical significance
was considered when P values were lower than 0.05.
RESULTS
EARLY INTERACTION OF UCB WITH THE HBMEC MONOLAYER
TRIGGERS THE UPREGULATION OF CAVEOLIN-1, VEGF AND VEGFR-2,
AS WELL AS THE RELEASE OF SMALL SIZED VESICLES
We began our studies by evaluating the effect of UCB on
caveolin-1, VEGF and VEGFR-2 levels, since these proteins are
important players in the mechanisms that regulate endothelial
permeability.
As shown in Figure 1, the exposure of HBMEC to both UCB
concentrations led to an initial increase in the immunostain-
ing of caveolin-1 that returned to near control levels afterwards
(Figure 1A). Maximum fluorescence was observed at 4 h, as rep-
resented in Figure 1B (increase of 56 and 91% for UCB 50 and
100μM, respectively, P < 0.05). In accordance, transmission EM
analysis of HBMEC also at 4 h (Figure 1C) evidenced an increased
number of caveolae in the UCB-treated cells.
Analysis of VEGF and VEGFR-2 fluorescence showed a sur-
prising pattern of immunostainnings. The cytokine appeared in
the perinuclear region, before secretion to the cultured medium
as previously observed by us after prolonged UCB exposure
(Palmela et al., 2011). On the other hand, receptor staining evi-
denced to not be restrained to the cell membrane but distributed
in the entire cell, probably as a consequence of the interac-
tion between VEGFR-2 and caveolae (Labrecque et al., 2003).
Interestingly, the fluorescence showed a progressive increase
from 4 to 24 h of exposure, decreasing to control levels after-
wards (Figures 2A,B, respectively). Maximum immunostaining
was observed at 24 h for both proteins (Figure 2C), correspon-
dent to an increase of∼16 and 12% in VEGF and VEGFR-2 levels,
respectively (P < 0.01).
As shown in Figure 3, the scanning EM analysis revealed that
during the early response to UCB (4 h incubation), a great num-
ber of vesicles with different sizes were released from the cells
treated with both UCB concentrations. Interestingly, the high-
est concentration produced a very significant release of small
vesicles, a distinct pattern from the one triggered by the lowest
concentration of UCB. Despite this observation, no alterations
were produced in the barrier properties of the monolayer or in
the levels of β-catenin and ZO-1 at this time point (results not
shown).
SUSTAINED INTERACTION OF UCB WITH THE HBMEC MONOLAYER
DETERMINES THE DOWN-REGULATION OF β-CATENIN AND
ZO-1 PROTEINS
Next, we evaluated the effect of UCB in proteins from the TJ and
AJ, ZO-1, and β-catenin, respectively, as they are key players in the
maintenance of barrier properties of endothelial cells of the BBB.
Since β-catenin has also a crucial role as a transcription fac-
tor in the Wnt/β-catenin signaling pathway (Liebner and Plate,
2010), its location is not only relevant in the membrane but also
in other subcellular regions. Therefore, we investigated if the cel-
lular distribution of β-catenin was disturbed by UCB. To evaluate
this, β-catenin levels were analyzed in three different subcellular
locations: nucleus, cytoplasm and plasmamembrane. As depicted
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FIGURE 1 | Early interaction of UCB with the HBMEC monolayer
increases the expression of caveolin-1 and triggers the formation of
caveolae. HBMEC line was incubated without (control) or with 50 or
100μM UCB, in the presence of 100μM HSA, for the indicated incubation
periods. Caveolin-1 was analyzed by immunocytochemistry and protein
levels were quantified by measurement of fluorescence intensity per number
of cells. Results are shown as fold change from respective control (A).
Representative immunocytochemistry results of the 4 h incubation point are
shown (B). Ultrastructural analysis by transmission electron microscopy
revealed an increased number of caveolae in UCB-treated cells (arrows)
(C). Results are means ± SEM from at least three independent experiments
performed in duplicate. ∗P < 0.05 vs. respective control.
in Figure 4A, the 24 h exposure to UCB caused a slight elevation
of total β-catenin with increases of ∼5% for both UCB concen-
trations (P < 0.05). Interestingly, and specially for the highest
UCB concentration, this minor elevation resulted from a bal-
ance between the upregulation of the nuclear fraction (increase
of 11%, P < 0.01) and a down-regulation of the membrane con-
tent (decrease of 15%, P < 0.01). This pattern of results was also
obtained for the 48 h period of incubation (Figure 4B), where the
effects to the β-catenin membrane fraction were more marked
between UCB concentrations (decrease of 7%, P < 0.05 and 18%,
P < 0.01 for UCB 50, and 100μM, respectively). After 72 h of
exposure to the highest concentration of UCB the minor eleva-
tion of nuclear β-catenin, along with the sustained decrease in
the membrane fraction, produced a significant decrease in total
protein (11%, P < 0.05) (Figure 4C).
ZO-1 immunostaining analysis (Figure 5A) revealed also
a decrease, although only evident after a 48 h interaction
(Figure 5B). This 26% reduction for UCB 50μM (P < 0.01) and
22% for UCB 100μM (P < 0.05) suggests a weakness of the
intercellular junctions. This alteration was corroborated either by
freeze-fracture analysis evidencing loss of TJ strands by both UCB
concentrations (Figure 5C), or scanning EM analysis also reveal-
ing increased number of retracted endothelial cells with deficient
cell-to-cell contacts in the UCB-treated samples (Figure 5D).
SUSTAINED INTERACTION OF UCB WITH THE HBMEC MONOLAYER
REDUCES THE TEER AND INCREASES THE PARACELLULAR
PERMEABILITY TO SF
TEER and permeability are crucial parameters for the study
of endothelial and epithelial barriers, reflecting the quality of
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FIGURE 2 | Early interaction of UCB with the HBMEC monolayer leads to
the upregulation of VEGF and VEGFR-2. HBMEC line was incubated
without (control) or with 50 or 100μM UCB, in the presence of 100μM HSA,
for the indicated incubation periods. VEGF and VEGFR-2 levels were analyzed
by immunocytochemistry and protein levels were quantified by measurement
of fluorescence intensity per number of cells. Quantification of VEGF (A) and
VEGFR-2 (B) levels is indicated as fold change from respective control.
Representative results of the 24 h period of incubation are shown (C).
Results are means ± SEM from at least five independent experiments
performed in duplicate. ∗P < 0.05 and ∗∗P < 0.01 vs. respective control.
the in vitro model and its paracellular barrier characteristics
(Wilhelm et al., 2011). By measuring these parameters we were
able to evaluate the consequences of UCB disturbance on an
otherwise tight barrier.
Figure 6A shows that exposure of the HBMEC monolayer to
100μM UCB led to a marked reduction of the TEER which,
though initiated after 24 h of exposure, attained a maximum 34%
decrease at 72 h incubation (P < 0.01). In accordance, the anal-
ysis of the HBMEC permeability to SF (Figure 6B) indicated a
progressive increase of the flux of this paracellular tracer along
the incubation time for the 100μM UCB, doubling its values at
72 h (P < 0.05).
SUSTAINED INTERACTION OF UCB WITH THE HBMEC MONOLAYER
ACTIVATES AUTOPHAGY
Autophagy is a highly regulated cellular process that serves
to remove damaged proteins and organelles from the cell
(Kimmelman, 2011). This complex phenomenon contributes
to the maintenance of cellular homeostasis, adaptation to
adverse environments and activation of programmed cell death
(Codogno and Meijer, 2005; Mizushima, 2007). The induced
conversion of LC3-I to LC3-II, the protein associated with the
autophagosomemembrane, is widely used to monitor autophagy
(Kabeya et al., 2000; Tanida et al., 2008). In order to under-
stand if in HBMEC this process is stimulated by UCB treatment,
we evaluated the protein levels of LC3 I and II. As depicted in
Figure 7, prolonged exposure to UCB enhanced the expression
of LC3-II, indicating a higher content of autophagosomes at 72 h
(P < 0.01).
SUSTAINED INTERACTION OF UCB WITH THE HBMEC MONOLAYER
CAUSES INCREASED UCB CELLULAR CONTENT, DETACHMENT
OF CELLS AND ENHANCED PASSAGE ACROSS THE MONOLAYER
Because Bf is believed to be the species crossing the BBB and its
quantification is assumed to be a better predictor of BIND risk
(Ahlfors, 2001; Ahlfors et al., 2009), we evaluated Bf levels in our
current experimental model. The UCB concentrations of 50 and
100μM(molar ratios of 0.5 and 1.0, respectively) yielded Bf levels
of 13.2 and 23.6 nM, respectively.
Our prior results indicated that a prolonged exposure of
the HBMEC monolayer to UCB increased the permeability,
which could facilitate the passage of UCB across the monolayer.
Therefore, we decided to measure the fraction of Bf that passed
from the upper chamber of the inserts (where HSA and UCB
were added, mimicking the systemic circulation) to the lower
chamber (mimicking the brain parenchyma). Values of Bf became
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FIGURE 3 | Early interaction of UCB with the HBMEC monolayer
determines the release of vesicles. HBMEC line was incubated without
(control) or with 50 or 100μM UCB, in the presence of 100μM HSA.
Analysis of vesicles released into culture medium was performed by
scanning electron microscopy and the results of the 4 h incubation
period are shown (A). Quantification of small (arrowhead), large
(arrow) and total number of vesicles is shown (B) and results are
means ± SEM from three independent experiments performed in
duplicate. ∗P < 0.05 and ∗∗P < 0.01 vs. control. ##P < 0.01 UCB 100 vs.
50μM.
significantly detectable only after 72 h incubation, mainly for the
highest UCB concentration used (Table 1).
Interestingly, a fraction of UCB remains inHBMEC as revealed
after chloroform extraction. The content of UCB in endothelial
cells showed a fivefold elevation in cells treated with 100μM as
compared with those exposed to 50μM for 72 h (Table 1). We
next sought to evaluate if the suggested UCB-induced fragility of
the monolayer also included the detachment of cells and cellular
fragments. As shown inTable 1, 100μMhad the greatest effect on
the detachment of cells, increasing the number of cells in suspen-
sion, either viable (twofold) or non-viable (12-fold), from both
the control condition and the lowest UCB concentration. These
results are in agreement with those of TEER and permeability, as
well as with those of Bf in the lower compartment and in HBMEC,
and yet with the release of vesicles observed by scanning EM, and
reflect a fragility of the monolayer that mainly occurs by exposure
to the highest UCB concentration in sustained conditions.
DISCUSSION
Though the role of the BBB in the progression, or even as a
cause of CNS disorders, has often been dismissed, it is nowa-
days believed that BBB dysfunction plays an important role in a
growing number of neurological pathologies, including cerebral
ischemia, brain trauma, tumors, and neurodegenerative diseases
(Zlokovic, 2008; Carvey et al., 2009; Weiss et al., 2009; Palmela
et al., 2012). In these conditions, peripheral factors includ-
ing toxins, monocytes, and complement more readily enter the
brain, but also chemokines, metabolites, and neurotransmitters
more freely leave the brain (Carvey et al., 2009). Therefore, a
compromised BBB may facilitate the passage of UCB into the
brain parenchyma (Wennberg, 2000), rendering the study of BBB
permeability and integrity of utmost importance. Nevertheless,
few studies have actually investigated how UCB passage across
the endothelial lining is achieved (Diamond and Schmid, 1966;
Sequeira et al., 2007) and the effects derived from the exposure
of brain endothelial cells to UCB (Akin et al., 2002; Palmela
et al., 2011; Cardoso et al., 2012). Interestingly, our data show
that features of UCB interaction with the HBMEC depend on
whether the exposure is short or prolonged. The early inter-
action of UCB affects the expression of caveolin-1, VEGF and
VEGFR-2. Although not affecting junctions, TEER and perme-
ability, a release of vesicles into the cultured media was observed
for both UCB concentrations, which already suggests endothe-
lial compromise. On the other hand, prolonged exposure to UCB
has drastic effects in HBMEC transendothelial properties, alter-
ing the intercellular junction structure and protein levels, as well
as inducing autophagy and UCB passage across the endothelial
lining.
Our interest in studying caveolin-1 was due to the complex
role of this protein in various signaling pathways that direct or
indirectly affect endothelial permeability, since it is associated
with proteins of the TJ and AJ (Nusrat et al., 2000; Song et al.,
2007). Moreover, interaction of caveolin-1 with VEGFR-2 sug-
gests a direct regulation of the receptor activity and a role in
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FIGURE 4 | UCB interaction with the HBMEC monolayer determines
an upregulation of nuclear β-catenin and a down-regulation in
the membrane fraction. HBMEC line was incubated without (control) or
with 50 or 100μM UCB, in the presence of 100μM HSA. β-catenin was
evaluated by immunofluorescence and Western blot analysis of different
subcellular locations (nucleus, cytoplasm, and membrane), after subcellular
fractionation. Representative immunofluorescence photos, as well as
representative Western blot results and respective quantification are shown
for the incubation periods of 24 h (A), 48 h (B), and 72 h (C). Quantification of
band intensity was done by scanning densitometry and standardized
with respect to total protein stains. Results are means ± SEM from
at least four independent experiments performed in duplicate.
∗P < 0.05 and ∗∗P < 0.01 vs. respective control; #P < 0.05 UCB 100 vs.
50μM.
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FIGURE 5 | Interaction of UCB with the HBMEC monolayer determines a
later down-regulation of ZO-1 protein. HBMEC line was incubated without
(control) or with 50 or 100μM UCB, in the presence of 100μM HSA, for the
indicated incubation periods. Total fluorescence of ZO-1 is shown as fold
change from respective control (A). Representative results, showing loss of
ZO-1 staining (arrows), after a 48 h period of incubation are shown (B). UCB
exposure induces loss of tight junction strands (arrows) at 48 h, as observed
by freeze-fracture (C). Scanning electron microscopy results evidence the
effects of UCB on the intercellular contacts after 48 h, showing retracted
endothelial cells (arrows) (D). Results are means ± SEM from at least three
independent experiments performed in duplicate. ∗P < 0.05 and ∗∗P < 0.01
vs. respective control.
modulation of permeability (Labrecque et al., 2003; Tahir et al.,
2009). Our results show that incubation with both UCB con-
centrations increase caveolin-1 expression after 4 h. In addition,
transmission EM analysis reveals a higher number of caveolae in
the UCB-treated cells. This is a very interesting fact since acti-
vation of caveolae-associated signaling proteins was indicated to
have a role in the uptake of toxicants (Majkova et al., 2010) and
upregulation of caveolin-1 has been associated with enhanced
transcytosis (Xia et al., 2009; Wang et al., 2010). In accordance
to Song et al. (2007) report that caveolin-1 acts to restrain
processes that destabilize endothelial junctions, we may hypoth-
esize that the upregulation at 4 h may translate an attempt to
stabilize the HBMEC junctions and prevent their disorganiza-
tion. Caveolin-1 is known to interact and inhibit VEGFR-2,
although allowing VEGFR-2 to undergo VEGF-dependent acti-
vation (Labrecque et al., 2003). This evidence suggests a role of
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FIGURE 6 | Prolonged interaction of UCB with the HBMEC monolayer
decreases TEER and increases paracellular permeability to sodium
fluorescein. HBMEC line was incubated without (control) or with 50 or
100μM UCB, in the presence of 100μM HSA, for the indicated
incubation periods. TEER, expressed as fold change from control
readings (A), and the transendothelial permeability (Pe) to sodium
fluorescein (B) are shown. Results are means ± SEM from at least six
independent experiments performed in duplicate. ∗P < 0.05 and
∗∗P < 0.01 vs. respective control. #P < 0.05 and ##P < 0.01 UCB 100 vs.
50μM.
FIGURE 7 | Prolonged interaction of UCB with the HBMEC monolayer
activates autophagy. HBMEC line was incubated without (control) or with
50 or 100μM UCB, in the presence of 100μM HSA, for the indicated
periods. Autophagy was evaluated by Western blot, with LC3 I (free form)
and II (phosphatidylethanolamine-conjugated form) detection.
Representative results of one experiment are shown (A). Quantification of
LC3 I and II band intensity was done by scanning densitometry
and the ratio between the membrane-bound and the cytosolic forms was
calculated and standardized with respect to β-actin protein (B). Results are
means ± SEM from at least four independent experiments performed in
duplicate. ∗P < 0.05 and ∗∗P < 0.01 vs. control. ##P < 0.01 UCB 100 vs.
50μM.
Table 1 | Distribution of UCB across the HBMEC monolayer and consequent damage after 72h of incubation.
Control UCB 50μM UCB 100μM
Free UCB (Bf)
Upper compartment (nM)
— 8.6 ± 0.7∗∗ 14.7 ± 0.3∗∗/##
Free UCB (Bf)
Lower compartment (nM)
— 0.2 ± 0.1 1.2 ± 0.1∗∗/##
Endothelial UCB
(nmol/mg protein)
— 2.4 ± 0.2 11.9 ± 2.8##
Viable cells in suspension
(cells/insert)
2000 ± 935 1667 ± 408 4250 ± 288∗/##
Non-viable cells in suspension
(cells/insert)
21,000 ± 7515 14,600 ± 6591 257,400 ± 56,346∗∗/##
HBMEC line was incubated without (control) or with 50 or 100µM UCB, in the presence of 100µM HSA, for 72 h. Free UCB was measured with the peroxidase
method. UCB content in endothelial cells was calculated after chloroform extraction. The analysis of viable and non-viable cells in suspension was evaluated with
the Trypan blue dye exclusion test. All results are means ± SEM from at least three independent experiments.
*P < 0.05 and **P < 0.01 vs. respective control.
##P < 0.01 UCB 100 vs. 50µM.
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caveolin-1 in conferring ligand dependence to this receptor sys-
tem and is in accordance to our results on VEGF and VEGFR-2
expression, evidencing that peak values shift from an increase of
caveolin-1 at 4 h to maximal levels of VEGF and VEGFR-2 at 24 h.
If after 4 h the reduced levels of VEGF and increased expression of
caveolin-1 might prevent VEGFR-2 activation, at 24 h this is no
longer present and VEGFR-2 increases. Stimulation of VEGFR-2
by VEGF is a key step in endothelial proliferation, migration and
increased permeability, ultimately contributing to the angiogenic
response (Holmes et al., 2007). Thus, our observed results with
VEGFR-2 support the increase in paracellular permeability by
UCB exposure, from 24 h onwards. Indeed, angiogenic sprout-
ing with the presence of immature blood vessels and blood-borne
components in brain parenchyma, suggesting an hyperpermeable
BBB, was recently observed in a premature infant with kernicterus
at autopsy (Brito et al., 2011).
Alterations produced by UCB in both TJ and AJ are only
observed at prolonged conditions. Although TJ are the primary
seal between endothelial cells, in BMEC, TJ and AJ are intermin-
gled and AJ also contribute to the properties of the BBB endothe-
lium (Cardoso et al., 2010). The AJ protein β-catenin plays an
important role in maintaining barrier function by influencing TJ
formation and directly activating signaling molecules and gene
transcription (Lampugnani and Dejana, 2007). In our study, we
questioned if UCB would alter β-catenin assembly, favoring any
subcellular distribution and function. β-catenin peaked between
24 and 48 h for both UCB concentrations, similarly to our pre-
vious observations obtained by Western blot analysis (Palmela
et al., 2011). Along the incubation period we observed an increase
in the nuclear fraction of β-catenin, while the membrane con-
tent of this protein was decreased. This shift in the subcellular
localization of β-catenin supports our results on the integrity
parameters, reflecting a reduction of the protein at the junc-
tional level and consequent fragility of the barrier. These effects
were less marked for the 50μM UCB, where total β-catenin
remained unaltered or superior than in control samples, which
supports the absence of effects on TEER and permeability with
this concentration. When considering the time-dependent effects
of 100μM UCB in β-catenin, i.e., an upregulation followed by
a great reduction of protein levels, we may assume that after an
attempt to circumvent the UCB induced-damage, β-catenin may
become vulnerable to UCB toxicity and further contribute to
the decline of HBMEC integrity. Importantly, our results show
a sustained β-catenin down-regulation in the membrane frac-
tion, reflecting its reduction at the junction level. To note that
VEGFR-2 stimulation by VEGF was shown to reduce the strength
of VE-cadherin association to β-catenin and to actin cytoskele-
ton, contributing to an increased permeability (Liebner et al.,
2006; Margariti et al., 2010). This corroborates our findings
in that VEGF and VEGFR-2 increased prior to the reduction
of β-catenin, and the alterations in TEER and permeability. It
has been indicated that the reduced β-catenin in the cytoplasm
is probably a consequence of protein degradation by polyu-
biquitination, as observed in other cell cultures (Zhang et al.,
2011), and that is related with both BBB breakdown (Liebner
et al., 2008) and cell death (Kim et al., 2010; Omori et al.,
2011).
The decrease of ZO-1 protein expression at 48 h observed in
this study is in line with the work of Raimondi et al. (2006)
showing that UCB decreased occludin in Caco-2 cells, an intesti-
nal epithelial cell line with barrier properties. The reduction we
observed in ZO-1 was supported by freeze-fracture EM show-
ing a decrease of TJ strands. In this regard, it was observed a
correlation between increased organization of TJ cytoplasmic fib-
rils and decreased membrane permeability (Huber et al., 2001).
Therefore, the poorer expression of ZO-1 and the less complex TJ
in UCB-treated cells shall underline the decrease in TEER and the
increase in the permeability to SF, supporting the lower capac-
ity to maintain intercellular contacts as indicated by scanning EM
analysis.
Curiously, in vasogenic cerebral edema, Nag et al. (2009b)
reported that augmented levels of caveolin-1 at the onset of
injury were followed by reduction and destabilization of TJ (late
event), resulting in increased endothelial permeability and BBB
breakdown (Zhong et al., 2008; Wang et al., 2011). We observed
this sequence of events during the exposure of HBMEC to UCB,
where prolonged incubation with the highest UCB concentration
led to a reduction in TEER and an increase in permeability. This
is not without precedent since it was previously shown in Caco-2
cells that Bf levels of 5–600 nM also triggered reduced TEER and
increased permeability (Raimondi et al., 2006). Similar results
were also recently obtained by us in rat brain endothelial cells,
either in mono- and in co-culture with astrocytes (Cardoso et al.,
2012).
The induction of autophagy occurs in response to extra or
intracellular stress, and is associated with the activation of pro-
grammed cell death through a cell-autodigestive process (Levine
and Klionsky, 2004; He and Klionsky, 2009). Since UCB-induced
apoptotic cell death was not only observed in HBMEC (Palmela
et al., 2011), but in other brain cells as well (Fernandes et al.,
2004; Silva et al., 2010; Vaz et al., 2010), we hypothesized
that UCB-mediated endothelial injury would include autophagy
activation. We have observed that, in fact, UCB, mainly the
highest concentration, induces the conversion of LC3-I (free
form) to LC3-II (phosphatidylethanolamine-conjugated form),
after 72 h of incubation. This provides the first demonstration
that autophagy is among the mechanisms of UCB-induced cell
death, at least in HBMEC. This finding indicates that UCB may
induce HBMEC senescence since recent studies disclosed that
autophagy facilitates the process of senescence (Young et al.,
2009), an association already observed in stressed endothelial
cells (Patschan et al., 2008). Curiously, the upregulation of genes
suggestive of an induced autophagy in human neuroblastoma
SH-SY5Y cells by exposure to UCB was previously indicated
(Calligaris et al., 2009) and surely deserves to be explored in the
future.
This study culminated in the evaluation of UCB passage across
the HBMEC monolayer. It is generally assumed that albumin-
bound UCB does not cross the intact BBB but that Bf readily
does it (Wennberg, 2000; Hansen, 2002). Our results showed that
the molar ratios of 0.5 and 1.0 used yielded levels of Bf compa-
rable to those found in the serum of neonates with moderate or
severe hyperbilirubinemia, respectively (Ahlfors et al., 2009). The
maximum decrease in Bf in the upper compartment after 72 h of
Frontiers in Cellular Neuroscience www.frontiersin.org May 2012 | Volume 6 | Article 22 | 11
Palmela et al. Bilirubin disrupts BBB transendothelial properties
FIGURE 8 | Effects of UCB on HBMEC differ between an early and
late exposure. HBMEC early response includes increased number of
caveolae and levels of caveolin-1 and VEGFR-2, while a delayed response
presents alterations in the transendothelial properties of the HBMEC
monolayer. This later response includes the disruption of the endothelial
junctions, deficient cell-to-cell contacts and consequent detachment of
cells, culminating in the passage of free UCB across the HBMEC
monolayer.
incubation, and the consequent increase in the lower compart-
ment, reflects the passage of the pigment across the endothelial
monolayer in the apical-basal direction, though not excluding
the passage in the opposite direction, as observed by other stud-
ies with bovine brain microvascular endothelial cells (Sequeira
et al., 2007). Additionally, and complementing our data, we
observed that intracellular UCB levels were directly correlated
with the concentration of UCB to which HBMEC were exposed
to. This fraction of UCB in endothelial cells probably accounts
for the HBMEC demise suggested by the autophagic activation,
and impairment of barrier properties here noticed. Moreover, the
observed cell detachment supported the notion of a fragile mono-
layer and perturbation of the endothelial integrity, particularly
for 100μM UCB, attesting the most harmful and acute effects
produced by severe hyperbilirubinemia.
In conclusion, our data demonstrate that UCB impairs barrier
function in an in vitro model of the human BBB. Interestingly,
this interaction involves dual effects that depend on the time of
incubation, with early transcytosis and late paracellular pathways
facilitating UCB entrance into the brain (Figure 8). Collectively,
these results underscore the need of prompt clinical interven-
tion in cases of lasting hyperbilirubinemia to prevent BIND and
related irreversible CNS damage.
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